304 related articles for article (PubMed ID: 16425095)
1. Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden).
Hedelin M; Klint A; Chang ET; Bellocco R; Johansson JE; Andersson SO; Heinonen SM; Adlercreutz H; Adami HO; Grönberg H; Bälter KA
Cancer Causes Control; 2006 Mar; 17(2):169-80. PubMed ID: 16425095
[TBL] [Abstract][Full Text] [Related]
2. Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer.
Hedelin M; Bälter KA; Chang ET; Bellocco R; Klint A; Johansson JE; Wiklund F; Thellenberg-Karlsson C; Adami HO; Grönberg H
Prostate; 2006 Oct; 66(14):1512-20. PubMed ID: 16921512
[TBL] [Abstract][Full Text] [Related]
3. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
[TBL] [Abstract][Full Text] [Related]
4. Phyto-oestrogens and risk of prostate cancer in Scottish men.
Heald CL; Ritchie MR; Bolton-Smith C; Morton MS; Alexander FE
Br J Nutr; 2007 Aug; 98(2):388-96. PubMed ID: 17403269
[TBL] [Abstract][Full Text] [Related]
5. Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland.
Pietinen P; Stumpf K; Männistö S; Kataja V; Uusitupa M; Adlercreutz H
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):339-44. PubMed ID: 11319174
[TBL] [Abstract][Full Text] [Related]
6. Plasma enterolactone and genistein and the risk of premenopausal breast cancer.
Piller R; Chang-Claude J; Linseisen J
Eur J Cancer Prev; 2006 Jun; 15(3):225-32. PubMed ID: 16679865
[TBL] [Abstract][Full Text] [Related]
7. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada).
Thanos J; Cotterchio M; Boucher BA; Kreiger N; Thompson LU
Cancer Causes Control; 2006 Dec; 17(10):1253-61. PubMed ID: 17111256
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of plasma enterolactone and prostate cancer risk (Sweden).
Stattin P; Bylund A; Biessy C; Kaaks R; Hallmans G; Adlercreutz H
Cancer Causes Control; 2004 Dec; 15(10):1095-102. PubMed ID: 15801493
[TBL] [Abstract][Full Text] [Related]
9. Plasma enterolactone and breast cancer incidence by estrogen receptor status.
Olsen A; Knudsen KE; Thomsen BL; Loft S; Stripp C; Overvad K; Møller S; Tjønneland A
Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2084-9. PubMed ID: 15598765
[TBL] [Abstract][Full Text] [Related]
10. Urinary phytoestrogens and postmenopausal breast cancer risk.
den Tonkelaar I; Keinan-Boker L; Veer PV; Arts CJ; Adlercreutz H; Thijssen JH; Peeters PH
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):223-8. PubMed ID: 11303591
[TBL] [Abstract][Full Text] [Related]
11. The association between dietary lignans, phytoestrogen-rich foods, and fiber intake and postmenopausal breast cancer risk: a German case-control study.
Zaineddin AK; Buck K; Vrieling A; Heinz J; Flesch-Janys D; Linseisen J; Chang-Claude J
Nutr Cancer; 2012; 64(5):652-65. PubMed ID: 22591208
[TBL] [Abstract][Full Text] [Related]
12. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers.
Kilkkinen A; Erlund I; Virtanen MJ; Alfthan G; Ariniemi K; Virtamo J
Am J Epidemiol; 2006 Apr; 163(8):687-93. PubMed ID: 16510545
[TBL] [Abstract][Full Text] [Related]
13. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study.
Vanharanta M; Voutilainen S; Rissanen TH; Adlercreutz H; Salonen JT
Arch Intern Med; 2003 May; 163(9):1099-104. PubMed ID: 12742810
[TBL] [Abstract][Full Text] [Related]
14. Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
Stattin P; Adlercreutz H; Tenkanen L; Jellum E; Lumme S; Hallmans G; Harvei S; Teppo L; Stumpf K; Luostarinen T; Lehtinen M; Dillner J; Hakama M
Int J Cancer; 2002 May; 99(1):124-9. PubMed ID: 11948503
[TBL] [Abstract][Full Text] [Related]
15. Phyto-oestrogen intake and breast cancer risk in South Asian women in England: findings from a population-based case-control study.
dos Santos Silva I; Mangtani P; McCormack V; Bhakta D; McMichael AJ; Sevak L
Cancer Causes Control; 2004 Oct; 15(8):805-18. PubMed ID: 15456994
[TBL] [Abstract][Full Text] [Related]
16. Validation of FFQ-based assessment of dietary lignans compared with serum enterolactone in Swedish women.
Lin Y; Wolk A; Håkansson N; Peñalvo JL; Lagergren J; Adlercreutz H; Lu Y
Br J Nutr; 2013 May; 109(10):1873-80. PubMed ID: 23006454
[TBL] [Abstract][Full Text] [Related]
17. Plasma enterolactone and risk of prostate cancer in middle-aged Swedish men.
Wallström P; Drake I; Sonestedt E; Gullberg B; Bjartell A; Olsson H; Adlercreutz H; Tikkanen MJ; Wirfält E
Eur J Nutr; 2018 Oct; 57(7):2595-2606. PubMed ID: 28884432
[TBL] [Abstract][Full Text] [Related]
18. Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).
Cotterchio M; Boucher BA; Kreiger N; Mills CA; Thompson LU
Cancer Causes Control; 2008 Apr; 19(3):259-72. PubMed ID: 17992574
[TBL] [Abstract][Full Text] [Related]
19. Phytoestrogens and prostate cancer risk.
Ganry O
Prev Med; 2005 Jul; 41(1):1-6. PubMed ID: 15916986
[TBL] [Abstract][Full Text] [Related]
20. Enterolactone is differently associated with estrogen receptor beta-negative and -positive breast cancer in a Swedish nested case-control study.
Sonestedt E; Borgquist S; Ericson U; Gullberg B; Olsson H; Adlercreutz H; Landberg G; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3241-51. PubMed ID: 18990767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
